TABLE 2 Pulmonary impedance measurements at baseline
ControlsCOPDCV# %
NonsmokingSmokingGOLD 2GOLD 3GOLD 4
Subjects n4618317918660
Rrs5 kPa·L−1·s−10.28 (0.47)0.29 (0.48)0.42 (0.67)0.46 (0.73)0.49 (0.72)5.3
 Insp0.27 (0.47)0.27 (0.43)0.37 (0.57)0.42 (0.63)0.45 (0.60)5.8
 Exp0.30 (0.53)0.31 (0.52)0.44 (0.70)0.47 (0.75)0.47 (0.78)6.4
Xrs5 kPa·L−1·s−1 median (fifth percentile)−0.07 (−0.16)−0.08 (−0.18)−0.15 (−0.42)−0.26 (−0.54)−0.40 (−0.66)
 Insp−0.08 (−0.14)−0.08 (−0.15)−0.14 (−0.23)−0.18 (−0.33)−0.24 (−0.46)
 Exp−0.07 (−0.18)−0.07 (−0.22)−0.17 (−0.54)−0.31 (−0.70)−0.51 (−0.88)
ΔXrs kPa·L−1·s−1−0.01 (0.04)−0.01 (0.07)0.04 (0.37)0.11 (0.51)0.26 (0.66)
fres Hz12.0 (16.0)11.5 (16.4)17.2 (24.8)20.0 (27.5)23.6 (31.2)4.0
 Insp10.9 (15.1)10.3 (15.5)16.5 (22.4)18.8 (25.7)21.5 (29.8)4.1
 Exp12.3 (17.9)12.3 (17.8)17.7 (26.5)20.4 (28.4)24.4 (31.2)5.1
  • Data are presented as median (95th percentile) unless otherwise stated. n=654. COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Chronic Obstructive Lung Disease; CV: coefficient of variation; Rrs5: resistance at 5 Hz; Insp: inspiratory; Exp: expiratory; Rrs5: reactance at 5 Hz; ΔXrs: difference between Insp and Exp values of Rrs5; fres: resonant frequency. #: mean over three measurements.